secwatch.observer — SEC 8-K summary
======================================

Issuer:     PACIFIC BIOSCIENCES OF CALIFORNIA, INC. (PACB)
CIK:        0001299130
Form:       8-K
Filed at:   2025-01-30T23:59:59+00:00
Accession:  0001299130-25-000015
Event type: leadership
Sentiment:  neutral
Materiality: 0.30
Item codes: 5.02, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

PacBio appoints NeoGenomics CEO Chris Smith to board; David Meline resigns
--------------------------------------------------------------------------

- Chris Smith, CEO of NeoGenomics (NEO), appointed to PacBio Board effective Jan 30, 2025.
- David Meline resigned from Board effective Jan 30, 2025; no disagreement cited.
- Smith brings diagnostics and genomics expertise as PacBio expands into clinical genomics.
- Smith previously led Ortho Clinical Diagnostics (sold to Quidel) and Cochlear Limited.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1299130/000129913025000015/0001299130-25-000015-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1299130/000129913025000015/pacb-20250124.htm
  HTML page:      https://secwatch.observer/filing/0001299130-25-000015

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer